tiprankstipranks
Trending News
More News >
Molina Healthcare (MOH)
NYSE:MOH
US Market

Molina Healthcare (MOH) Ratios

Compare
1,170 Followers

Molina Healthcare Ratios

MOH's free cash flow for Q4 2025 was $0.06. For the 2025 fiscal year, MOH's free cash flow was decreased by $ and operating cash flow was $-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.69 1.69 1.62 1.54 1.47
Quick Ratio
1.69 1.69 1.62 1.54 1.47
Cash Ratio
0.58 0.58 0.59 0.59 0.58
Solvency Ratio
0.06 0.06 0.12 0.12 0.10
Operating Cash Flow Ratio
-0.07 -0.07 0.08 0.20 0.11
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 949.00M$ 949.00M$ 1.64B$ 1.86B$ 734.00M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.25 0.20 0.16 0.19
Debt-to-Equity Ratio
0.97 0.97 0.69 0.57 0.81
Debt-to-Capital Ratio
0.49 0.49 0.41 0.36 0.45
Long-Term Debt-to-Capital Ratio
0.48 0.48 0.39 0.34 0.42
Financial Leverage Ratio
3.83 3.83 3.48 3.53 4.15
Debt Service Coverage Ratio
4.47 4.47 12.57 12.58 9.80
Interest Coverage Ratio
4.07 4.07 14.47 14.43 10.66
Debt to Market Cap
0.51 0.43 0.17 0.10 0.11
Interest Debt Per Share
81.55 81.55 56.38 42.93 43.27
Net Debt to EBITDA
-0.31 -0.31 -0.82 -1.41 -1.20
Profitability Margins
Gross Profit Margin
8.97%8.97%11.65%12.72%12.28%
EBIT Margin
1.72%1.72%4.20%4.62%3.67%
EBITDA Margin
2.15%2.15%4.66%5.12%4.22%
Operating Profit Margin
1.72%1.72%4.20%4.62%3.67%
Pretax Profit Margin
1.30%1.30%3.91%4.30%3.32%
Net Profit Margin
1.04%1.04%2.90%3.20%2.48%
Continuous Operations Profit Margin
1.04%1.04%2.90%3.20%2.48%
Net Income Per EBT
80.14%80.14%74.20%74.52%74.51%
EBT Per EBIT
75.42%75.42%93.09%93.07%90.62%
Return on Assets (ROA)
3.03%3.03%7.54%7.33%6.43%
Return on Equity (ROE)
10.99%11.60%26.22%25.88%26.72%
Return on Capital Employed (ROCE)
9.53%9.53%22.07%23.39%21.49%
Return on Invested Capital (ROIC)
7.64%7.64%16.38%17.43%16.01%
Return on Tangible Assets
3.53%3.53%8.61%8.12%7.25%
Earnings Yield
6.45%5.35%7.06%5.20%4.15%
Efficiency Ratios
Receivables Turnover
12.86 12.86 12.32 10.98 13.89
Payables Turnover
0.00 0.00 26.98 23.75 31.55
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
150.92 150.92 141.15 126.19 123.45
Asset Turnover
2.92 2.92 2.60 2.29 2.60
Working Capital Turnover Ratio
8.96 9.13 8.79 8.96 10.24
Cash Conversion Cycle
28.39 28.39 16.09 17.89 14.71
Days of Sales Outstanding
28.39 28.39 29.62 33.25 26.28
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 13.53 15.37 11.57
Operating Cycle
28.39 28.39 29.62 33.25 26.28
Cash Flow Ratios
Operating Cash Flow Per Share
-10.53 -10.53 11.22 28.61 13.37
Free Cash Flow Per Share
-12.52 -12.52 9.48 27.16 11.80
CapEx Per Share
1.99 1.99 1.74 1.45 1.57
Free Cash Flow to Operating Cash Flow
1.19 1.19 0.84 0.95 0.88
Dividend Paid and CapEx Coverage Ratio
-5.30 -5.30 6.44 19.79 8.49
Capital Expenditure Coverage Ratio
-5.30 -5.30 6.44 19.79 8.49
Operating Cash Flow Coverage Ratio
-0.14 -0.14 0.21 0.70 0.32
Operating Cash Flow to Sales Ratio
-0.01 -0.01 0.02 0.05 0.02
Free Cash Flow Yield
-8.58%-7.22%3.26%7.52%3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.49 18.68 14.17 19.24 24.10
Price-to-Sales (P/S) Ratio
0.16 0.19 0.41 0.62 0.60
Price-to-Book (P/B) Ratio
1.80 2.17 3.72 4.98 6.44
Price-to-Free Cash Flow (P/FCF) Ratio
-11.66 -13.86 30.71 13.30 27.99
Price-to-Operating Cash Flow Ratio
-13.67 -16.48 25.94 12.63 24.69
Price-to-Earnings Growth (PEG) Ratio
-0.33 -0.33 1.46 0.53 1.19
Price-to-Fair Value
1.80 2.17 3.72 4.98 6.44
Enterprise Value Multiple
7.29 8.73 8.01 10.62 12.95
Enterprise Value
7.12B 8.52B 15.16B 18.53B 17.47B
EV to EBITDA
7.29 8.73 8.01 10.62 12.95
EV to Sales
0.16 0.19 0.37 0.54 0.55
EV to Free Cash Flow
-11.19 -13.39 27.87 11.74 25.62
EV to Operating Cash Flow
-13.30 -15.92 23.54 11.15 22.60
Tangible Book Value Per Share
36.89 36.89 44.56 47.61 27.23
Shareholders’ Equity Per Share
80.11 80.11 78.33 72.55 51.28
Tax and Other Ratios
Effective Tax Rate
0.20 0.20 0.26 0.25 0.25
Revenue Per Share
894.32 894.32 708.19 586.44 553.18
Net Income Per Share
9.29 9.29 20.54 18.78 13.70
Tax Burden
0.80 0.80 0.74 0.75 0.75
Interest Burden
0.75 0.75 0.93 0.93 0.91
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.07 0.07 0.07 0.07
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
-1.13 -1.13 0.55 1.52 0.98
Currency in USD